These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 28962076)
1. miR-217 inhibits proliferation, migration, and invasion via targeting AKT3 in thyroid cancer. Lin Y; Cheng K; Wang T; Xie Q; Chen M; Chen Q; Wen Q Biomed Pharmacother; 2017 Nov; 95():1718-1724. PubMed ID: 28962076 [TBL] [Abstract][Full Text] [Related]
2. MicroRNA-203 restrains epithelial-mesenchymal transition, invasion and migration of papillary thyroid cancer by downregulating AKT3. You A; Fu L; Li Y; Li X; You B Cell Cycle; 2020 May; 19(10):1105-1121. PubMed ID: 32308106 [TBL] [Abstract][Full Text] [Related]
3. Circ_0016760 accelerates non-small-cell lung cancer progression through miR-646/AKT3 signaling in vivo and in vitro. Chen S; Zhou L; Ran R; Huang J; Zheng Y; Xing M; Cai Y Thorac Cancer; 2021 Dec; 12(23):3223-3235. PubMed ID: 34658165 [TBL] [Abstract][Full Text] [Related]
4. miR-29a suppresses growth and metastasis in papillary thyroid carcinoma by targeting AKT3. Li R; Liu J; Li Q; Chen G; Yu X Tumour Biol; 2016 Mar; 37(3):3987-96. PubMed ID: 26482618 [TBL] [Abstract][Full Text] [Related]
5. CircWHSC1 regulates malignancy and glycolysis by the miR-212-5p/AKT3 pathway in triple-negative breast cancer. Ding L; Xie Z Exp Mol Pathol; 2021 Dec; 123():104704. PubMed ID: 34624276 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA‑497 inhibits cellular proliferation, migration and invasion of papillary thyroid cancer by directly targeting AKT3. Zhuang J; Ye Y; Wang G; Ni J; He S; Hu C; Xia W; Lv Z Mol Med Rep; 2017 Nov; 16(5):5815-5822. PubMed ID: 28849051 [TBL] [Abstract][Full Text] [Related]
7. miR-224-5p inhibits proliferation, migration, and invasion by targeting PIK3R3/AKT3 in uveal melanoma. Li J; Liu X; Li C; Wang W J Cell Biochem; 2019 Aug; 120(8):12412-12421. PubMed ID: 30825222 [TBL] [Abstract][Full Text] [Related]
8. Circ_0000144 facilitates the progression of thyroid cancer via the miR-217/AKT3 pathway. Fan YX; Shi HY; Hu YL; Jin XL J Gene Med; 2020 Dec; 22(12):e3269. PubMed ID: 32890417 [TBL] [Abstract][Full Text] [Related]
9. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p. Wang D; Zheng Y Endocr J; 2021 May; 68(5):583-597. PubMed ID: 33612561 [TBL] [Abstract][Full Text] [Related]
10. A novel lncRNA n384546 promotes thyroid papillary cancer progression and metastasis by acting as a competing endogenous RNA of miR-145-5p to regulate AKT3. Feng J; Zhou Q; Yi H; Ma S; Li D; Xu Y; Wang J; Yin S Cell Death Dis; 2019 Jun; 10(6):433. PubMed ID: 31160577 [TBL] [Abstract][Full Text] [Related]
11. Down-regulation of miR-9 promotes epithelial mesenchymal transition via regulating anoctamin-1 (ANO1) in CRC cells. Park YR; Lee ST; Kim SL; Zhu SM; Lee MR; Kim SH; Kim IH; Lee SO; Seo SY; Kim SW Cancer Genet; 2019 Feb; 231-232():22-31. PubMed ID: 30803553 [TBL] [Abstract][Full Text] [Related]
12. Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer. Huang Y; Ni R; Wang J; Liu Y Biomed Pharmacother; 2019 Jan; 109():1851-1859. PubMed ID: 30551440 [TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA TP73-AS1 sponges miR-194 to promote colorectal cancer cell proliferation, migration and invasion via up-regulating TGFα. Cai Y; Yan P; Zhang G; Yang W; Wang H; Cheng X Cancer Biomark; 2018; 23(1):145-156. PubMed ID: 30010111 [TBL] [Abstract][Full Text] [Related]
14. MiR-577 inhibits papillary thyroid carcinoma cell proliferation, migration and invasion by targeting SphK2. Xue KC; Hu DD; Zhao L; Li N; Shen HY Eur Rev Med Pharmacol Sci; 2017 Oct; 21(17):3794-3800. PubMed ID: 28975989 [TBL] [Abstract][Full Text] [Related]
15. MicroRNA-1271 inhibits the progression of papillary thyroid carcinoma by targeting IRS1 and inactivating AKT pathway. Chen Y; Hao SA; Jiang Y; Gao B; Tian WG; Zhang S; Guo LJ; Wang LL; Luo DL Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7989-7999. PubMed ID: 31599424 [TBL] [Abstract][Full Text] [Related]
16. Upregulation of circ_0000142 promotes multiple myeloma progression by adsorbing miR-610 and upregulating AKT3 expression. Liu F; Wang YL; Wei JM; Huang ZD J Biochem; 2021 Apr; 169(3):327-336. PubMed ID: 32970816 [TBL] [Abstract][Full Text] [Related]
17. miR-485-3p regulated by MALAT1 inhibits osteosarcoma glycolysis and metastasis by directly suppressing c-MET and AKT3/mTOR signalling. Wang Q; Liu MJ; Bu J; Deng JL; Jiang BY; Jiang LD; He XJ Life Sci; 2021 Mar; 268():118925. PubMed ID: 33358903 [TBL] [Abstract][Full Text] [Related]
18. LncRNA HOTTIP promotes papillary thyroid carcinoma cell proliferation, invasion and migration by regulating miR-637. Yuan Q; Liu Y; Fan Y; Liu Z; Wang X; Jia M; Geng Z; Zhang J; Lu X Int J Biochem Cell Biol; 2018 May; 98():1-9. PubMed ID: 29474928 [TBL] [Abstract][Full Text] [Related]
19. miR-215 suppresses papillary thyroid cancer proliferation, migration, and invasion through the AKT/GSK-3β/Snail signaling by targeting ARFGEF1. Han J; Zhang M; Nie C; Jia J; Wang F; Yu J; Bi W; Liu B; Sheng R; He G; Kong L; Zheng L; Pang R; Ding Z; Chen L; Guan Q; Pan S; Meng X; Xu J; Liu L; Zhang J Cell Death Dis; 2019 Feb; 10(3):195. PubMed ID: 30814512 [TBL] [Abstract][Full Text] [Related]
20. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer. Zhou Y; Li S; Li J; Wang D; Li Q Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]